Pharmaceutical Mutual funds are funds which primarily invest in pharmaceutical stocks in India.
Since these mutual funds invest money in a single theme/sector, they are categorized as High Risk equity investments.
| Mutual Fund Scheme | NAV | Month | 3 Month | 6 Month | Year | 2 Year | 3 Year | As on (yy-mm-dd) |
|---|---|---|---|---|---|---|---|---|
| Reliance Pharma Fund - Direct Plan Growth Plan - Growth Option | 139.8 | -6.87% | -3.47% | -1.78% | 11.58% | 5.66% | 1.84% | 2018-05-23 |
| Reliance Pharma Fund-Growth Plan-Growth Option | 133.8 | -6.92% | -3.67% | -2.22% | 10.56% | 3.81% | -0.88% | 2018-05-23 |
| UTI Pharma & Healthcare Fund-Income Option-Direct | 63.7 | -8.90% | -8.81% | -8.91% | -0.76% | -6.78% | -16.52% | 2018-05-23 |
| UTI Pharma & Healthcare Fund-Growth Option- Direct | 82.4 | -8.91% | -8.81% | -8.91% | -0.77% | -6.79% | -16.53% | 2018-05-23 |
| UTI Pharma & Healthcare Fund-Income Option | 60.7 | -8.98% | -9.03% | -9.37% | -1.76% | -8.50% | -18.86% | 2018-05-23 |
| UTI Pharma & Healthcare Fund-Growth Option | 78.6 | -8.99% | -9.04% | -9.38% | -1.76% | -8.50% | -18.86% | 2018-05-23 |
| Tata India Pharma & Healthcare Fund-Direct Plan-Growth | 8.4 | -9.23% | -6.70% | -6.90% | -4.57% | -8.93% | NA | 2018-05-23 |
| SBI PHARMA - DIRECT PLAN -GROWTH | 118.0 | -9.49% | -9.23% | -12.13% | -5.83% | -13.66% | -18.03% | 2018-05-23 |
| Tata India Pharma & Healthcare Fund-Regular Plan-Growth | 8.0 | -9.37% | -7.06% | -7.70% | -6.08% | -11.95% | NA | 2018-05-23 |
| SBI PHARMA - REGULAR PLAN -GROWTH | 111.3 | -9.59% | -9.52% | -12.68% | -6.99% | -15.75% | -21.04% | 2018-05-23 |